Meridian Bioscience

Meridian Bioscience

World Rank (Jan-05-2024)
6,902
World Rank (Jul-30-2023)
6,902
Market Cap (Jul-30-2023)
1.490 Billion USD
World Rank (Jan-07-2022)
10,067
Market Cap (Jan-07-2022)
0.892 Billion USD
World Rank (Jan-01-2021)
8,881
Market Cap (Jan-01-2021)
0.806 Billion USD
Headquarters Country
USA
Employee Count
560
Employee Count as of Date
As on 2021
Headquarters City/State
New York
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
317 Million USD
Annual Net Income in USD
71 Million USD
Annual Results for Period Ending
Sep-2021 ending year
Total Assets in USD
449 Million USD
Total Liabilities in USD
121 Million USD
Total Equity in USD
328 Million USD
Balance Sheet for Period Ending
Sep-2021 ending year
Business Sector
Healthcare
Biotechnology
Technology
HealthCare Products
Health Care Diagnostics
Company Website
MERIDIAN BIOSCIENCE
Yahoo
Yahoo @ Nasdaq
Company Profile

Meridian offers diagnostic manufacturers the complete solution with over 3,000 antigens and antibodies covering more than 500 disease targets and an extensive range of specialty qPCR master mixes and molecular enzymes manufactured under ISO13485 regulations. Meridian offers diagnostic manufacturers the complete solution. The headquarters is in USA.

Meridian Bioscience was acquired by SD Biosensor and SJL Partners in 2022.

Founded Year
1977
IPO Year
1986

Share